Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Jiangsu Sihuan Bioengineering Co Ltd Announces FY 2013 Q1 to Q3 Net Profit Outlook


Monday, 14 Oct 2013 08:00pm EDT 

Jiangsu Sihuan Bioengineering Co Ltd announced that it expects its net profit for the first three quarters of fiscal year (FY) 2013 to be approximately RMB 1,500,000 to RMB 3,000,000, compared to the net profit of the same period in FY 2012 (RMB 3,183,000). The Company cited the decrease in profit from Beijing-based biopharmaceutical subsidiary and increase in cost from Xinjiang-based technology subsidiary as the main reasons for the forecast. 

Company Quote